My Portfolio
+
LINK YOUR PORTFOLIO

Amgen Inc AMGN:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:20 PM EDT
339.86quote price arrow up+1.64 (+0.48%)
Volume
93,424
Close
338.22quote price arrow up+9.96 (+3.03%)
Volume
2,185,754
52 week range
267.83 - 391.29
Loading...
  • Open327.98
  • Day High338.70
  • Day Low325.98
  • Prev Close328.26
  • 52 Week High391.29
  • 52 Week High Date03/02/26
  • 52 Week Low267.83
  • 52 Week Low Date06/23/25

Latest On Amgen Inc

Key Stats

  • Market Cap182.54B
  • Shares Out539.71M
  • 10 Day Average Volume2.33M
  • Dividend10.08
  • Dividend Yield2.98%
  • Beta0.42

KEY STATS

  • Open327.98
  • Day High338.70
  • Day Low325.98
  • Prev Close328.26
  • 52 Week High391.29
  • 52 Week High Date03/02/26
  • 52 Week Low267.83
  • 52 Week Low Date06/23/25
  • Market Cap182.54B
  • Shares Out539.71M
  • 10 Day Average Volume2.33M
  • Dividend10.08
  • Dividend Yield2.98%
  • Beta0.42

RATIOS/PROFITABILITY

  • EPS (TTM)14.38
  • P/E (TTM)23.51
  • Fwd P/E (NTM)14.94
  • EBITDA (TTM)17.113B
  • ROE (TTM)101.32%
  • Revenue (TTM)37.22B
  • Gross Margin (TTM)71.55%
  • Net Margin (TTM)20.96%
  • Debt To Equity (MRQ)623.75%

EVENTS

  • Earnings Date08/03/2026(est)
  • Ex Div Date05/15/2026
  • Div Amount2.52
  • Split Date-
  • Split Factor-

Related Video

Calls of the Day: Eli Lilly, UnitedHealth and the XBI
VIDEO4:0404:04
Calls of the Day: Eli Lilly, UnitedHealth and the XBI

Profile

MORE
Amgen Inc. is a biotechnology company. It discovers, develops, manufactures and delivers medicines for the toughest diseases. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve people’s lives. It operates in the human therapeutics segment. Its marketed products portfolio includes EPOGEN (epoetin alfa); Aranesp (darbepoetin alfa); Parsabiv (etelcalcetide); Neulasta (pegfilgrastim); KANJINTI (trastuzumab-anns);...
Robert Bradway
Chairman of the Board, President, Chief Executive Officer
Peter Griffith
Chief Financial Officer, Executive Vice President
David Reese
Executive Vice President, Co-Chief Technology Officer
Murdo Gordon
Executive Vice President - Amgen Global Markets and Policy
Esteban Santos
Executive Vice President - Operations
Address
One Amgen Center Drive
Thousand Oaks, CA
91320-1799
United States